Cam Gallagher

Cam is a co-founder and President at Zentalis Pharmaceuticals and has served as a member of the Board of Directors since the Company’s founding. He has 30 years of experience in the life sciences, with a focus on corporate development, marketing and company formation, and financing. In addition to Zentalis, Cam currently serves on the Board of Directors of Ocuphire, Helios, SelectION, and Ray Therapeutics. He was also a founding Board member of VelosBio until its acquisition by Merck. From April 2016 to May 2022, he was the Chief Business Officer of Immusoft, a private company developing gene-modified cell therapies for orphan diseases. Previously, Cam was a board member and Chief Business Officer at Retrosense Therapeutics, which was acquired by Allergan. He was also the Managing Director of Nerveda, LLC, a life science seed fund he co-founded in June 2007. Prior to these roles, he held leadership positions at Oncternal, Zavante, Verus Pharma, CV Therapeutics, and Dura Pharma. Cam holds an MBA from the University of San Diego and a BS in Business Administration from Ohio University.